跳至主要内容
MedPath Trial Home
临床试验
产品
机构
资讯
AI 研究
价格
Search
EN
登录
我们重视您的隐私
我们使用 Cookie 分析网站流量并改善您的体验。请参阅我们的
隐私政策
。
拒绝
接受
找到 12,090 条关于
“FcRn receptor”
全部
12,090
临床试验
5,783
药物
1,331
机构
30
资讯
4,946
去年
Nipocalimab Granted FDA Breakthrough Therapy Designation for Sjögren's Disease
11个月前
First-in-Class FcRn Inhibitor Prevents Congenital Heart Block in High-Risk Pregnancy
2年前
VYVGART Hytrulo Approved by FDA as First FcRn Blocker for CIDP Treatment
去年
Rozanolixizumab Self-Administration Study Shows Promise for Myasthenia Gravis Patients
去年
Johnson & Johnson Halts Rheumatoid Arthritis Trial for Nipocalimab, Refocuses on Rare Disease Markets
去年
FcRn Inhibitors Show Promise in Autoimmune Disease Treatment, Market Set for Growth
去年
Efgartigimod Shows Promise in Treating Rare Neurological Autoimmune Disorders Beyond Myasthenia Gravis
去年
VYVDURA Approved in Japan for Chronic Inflammatory Demyelinating Polyneuropathy
去年
Myasthenia Gravis Market Set to Reach $10.3 Billion by 2034 Driven by Seven Late-Stage Pipeline Therapies
12个月前
Novartis Ianalumab Combination Shows 45% Improvement in ITP Disease Control in Phase III Trial
第 1 页,共 495 页
上一页
下一页